一种理解癌症免疫治疗时代种族差异的生物心理社会模型。
A biopsychosocial model to understand racial disparities in the era of cancer immunotherapy.
机构信息
Department of Cancer Prevention and Control, Roswell Park Comprehensive Cancer Center, Buffalo, NY, USA.
Department of Cancer Prevention and Control, Roswell Park Comprehensive Cancer Center, Buffalo, NY, USA.
出版信息
Trends Cancer. 2023 Jan;9(1):6-8. doi: 10.1016/j.trecan.2022.10.002. Epub 2022 Oct 22.
Abstract
The approval and wide uptake of immune checkpoint inhibitors (ICIs) in oncology practice raise the concerns of possibly worsened racial disparities in cancer treatment due to biological and psychosocial reasons. We propose a multilevel biopsychosocial model to understand the opportunities and challenges to racial disparities in the era of cancer immunotherapy.
摘要
免疫检查点抑制剂 (ICI) 在肿瘤学实践中的广泛批准和采用引起了人们的担忧，即由于生物学和社会心理原因，癌症治疗中的种族差异可能会恶化。我们提出了一个多层次的生物心理社会模型，以了解癌症免疫治疗时代种族差异的机遇和挑战。
相似文献
1
A biopsychosocial model to understand racial disparities in the era of cancer immunotherapy.一种理解癌症免疫治疗时代种族差异的生物心理社会模型。
Trends Cancer. 2023 Jan;9(1):6-8. doi: 10.1016/j.trecan.2022.10.002. Epub 2022 Oct 22.
2
Modulation of gut microbiota to overcome resistance to immune checkpoint blockade in cancer immunotherapy.调节肠道菌群以克服癌症免疫治疗中免疫检查点阻断的耐药性。
Curr Opin Pharmacol. 2020 Oct;54:1-10. doi: 10.1016/j.coph.2020.06.004. Epub 2020 Jun 30.
3
Incorporating Radiation Oncology into Immunotherapy: proceedings from the ASTRO-SITC-NCI immunotherapy workshop.将放射肿瘤学纳入免疫治疗：ASTRO-SITC-NCI 免疫治疗研讨会会议记录。
J Immunother Cancer. 2018 Jan 29;6(1):6. doi: 10.1186/s40425-018-0317-y.
4
A new biological triangle in cancer: intestinal microbiota, immune checkpoint inhibitors and antibiotics.癌症中新的生物学三角：肠道微生物群、免疫检查点抑制剂和抗生素。
Clin Transl Oncol. 2021 Dec;23(12):2415-2430. doi: 10.1007/s12094-021-02659-w. Epub 2021 Jun 14.
5
Interventional therapy combined with immune checkpoint inhibitors: Emerging opportunities for cancer treatment in the era of immunotherapy.介入治疗联合免疫检查点抑制剂：免疫治疗时代癌症治疗的新机遇。
Cancer Treat Rev. 2019 Mar;74:49-60. doi: 10.1016/j.ctrv.2018.08.006. Epub 2018 Aug 20.
6
Using the Biopsychosocial Model to Guide Patient-Centered Neurological Treatments.运用生物-心理-社会模式指导以患者为中心的神经科治疗。
Semin Neurol. 2022 Apr;42(2):80-87. doi: 10.1055/s-0041-1742145. Epub 2022 Feb 3.
7
Targeting protein kinases benefits cancer immunotherapy.靶向蛋白激酶有益于癌症免疫疗法。
Biochim Biophys Acta Rev Cancer. 2022 Jul;1877(4):188738. doi: 10.1016/j.bbcan.2022.188738. Epub 2022 Jun 2.
8
HLA-G/ILTs Targeted Solid Cancer Immunotherapy: Opportunities and Challenges.HLA-G/ILTs 靶向实体瘤免疫治疗：机遇与挑战。
Front Immunol. 2021 Jun 30;12:698677. doi: 10.3389/fimmu.2021.698677. eCollection 2021.
9
Ongoing Phase I Studies of Immune Checkpoint Inhibitors in China.中国正在进行的免疫检查点抑制剂 I 期研究。
Oncologist. 2019 Feb;24(Suppl 1):S11-S20. doi: 10.1634/theoncologist.2019-IO-S1-s03.
10
Experiences of cancer immunotherapy with immune checkpoint inhibitors (ExCIm)-insights of people affected by cancer and healthcare professionals: a qualitative study protocol.癌症免疫治疗中免疫检查点抑制剂的体验（ExCIm）——癌症患者和医疗保健专业人员的观点：一项定性研究方案。
BMJ Open. 2021 May 27;11(5):e043750. doi: 10.1136/bmjopen-2020-043750.
引用本文的文献
1
Cancer immunotherapy clinical trials to support urgently needed access in low- and middle-income countries: a report from the SITC global access and impact committee.支持低收入和中等收入国家迫切需要的癌症免疫疗法临床试验：SITC全球准入与影响委员会的报告
J Immunother Cancer. 2025 Jun 22;13(6):e011258. doi: 10.1136/jitc-2024-011258.
2
Comparative effectiveness of immunotherapy versus lenvatinib in advanced hepatocellular carcinoma: A real-world analysis using target trial emulation.免疫疗法与乐伐替尼治疗晚期肝细胞癌的疗效比较：一项采用目标试验模拟的真实世界分析。
Hepatology. 2025 Mar 28. doi: 10.1097/HEP.0000000000001328.
3
Receiving immunotherapy for the treatment of advanced renal cell carcinoma is associated with higher burden of illness, coagulopathy, cardiac arrhythmia, and disparities.接受免疫疗法治疗晚期肾细胞癌与更高的疾病负担、凝血病、心律失常及差异相关。
Support Care Cancer. 2025 Mar 15;33(4):285. doi: 10.1007/s00520-025-09353-5.
4
Trends and Disparities in the Use of Immunotherapy for Triple-Negative Breast Cancer in the US.美国三阴性乳腺癌免疫治疗使用情况的趋势与差异
JAMA Netw Open. 2025 Feb 3;8(2):e2460243. doi: 10.1001/jamanetworkopen.2024.60243.
5
Examining Patient Characteristics in Bladder Cancer Clinical Trials Involving Immunotherapy.在涉及免疫疗法的膀胱癌临床试验中研究患者特征。
J Clin Med. 2025 Jan 29;14(3):879. doi: 10.3390/jcm14030879.
6
Under-Representation and Under-Reporting of Minoritized Racial and Ethnic Groups in Clinical Trials on Immune Checkpoint Inhibitors.免疫检查点抑制剂临床试验中少数族裔种族和民族群体的代表性不足及报告不足
JCO Oncol Pract. 2025 Mar;21(3):408-417. doi: 10.1200/OP.24.00033. Epub 2024 Aug 22.
本文引用的文献
1
The distinct impacts of race and genetic ancestry on health.种族和遗传血统对健康的不同影响。
Nat Med. 2022 May;28(5):890-893. doi: 10.1038/s41591-022-01796-1.
2
Cancer statistics, 2022.癌症统计数据，2022 年。
CA Cancer J Clin. 2022 Jan;72(1):7-33. doi: 10.3322/caac.21708. Epub 2022 Jan 12.
3
Racial Differences in Survival Among Advanced-stage Non-small-Cell Lung Cancer Patients Who Received Immunotherapy: An Analysis of the US National Cancer Database (NCDB).接受免疫治疗的晚期非小细胞肺癌患者生存的种族差异：美国国家癌症数据库（NCDB）分析
J Immunother. 2022;45(2):132-137. doi: 10.1097/CJI.0000000000000400.
4
Immune-Based Cancer Treatment: Addressing Disparities in Access and Outcomes.免疫疗法治疗癌症：解决获取和结果方面的差异。
Am Soc Clin Oncol Educ Book. 2021 Mar;41:1-13. doi: 10.1200/EDBK_323523.
5
Biological Aspects of Cancer Health Disparities.癌症健康差异的生物学方面。
Annu Rev Med. 2021 Jan 27;72:229-241. doi: 10.1146/annurev-med-070119-120305.
6
Race and Genetic Ancestry in Medicine - A Time for Reckoning with Racism.医学中的种族与遗传血统——正视种族主义的时刻
N Engl J Med. 2021 Feb 4;384(5):474-480. doi: 10.1056/NEJMms2029562. Epub 2021 Jan 6.
7
Breast Tumor Microenvironment in Black Women: A Distinct Signature of CD8+ T-Cell Exhaustion.黑人女性的乳腺肿瘤微环境：CD8+ T 细胞耗竭的独特特征。
J Natl Cancer Inst. 2021 Aug 2;113(8):1036-1043. doi: 10.1093/jnci/djaa215.
8
Protective Innate Immune Variants in Racial/Ethnic Disparities of Breast and Prostate Cancer.种族/民族差异与乳腺癌和前列腺癌中保护性先天免疫变异体。
Cancer Immunol Res. 2019 Sep;7(9):1384-1389. doi: 10.1158/2326-6066.CIR-18-0564.
9
Enrollment of Racial Minorities in Clinical Trials: Old Problem Assumes New Urgency in the Age of Immunotherapy.临床试验中少数族裔的招募：在免疫治疗时代，老问题有了新的紧迫性。
Am Soc Clin Oncol Educ Book. 2019 Jan;39:3-10. doi: 10.1200/EDBK_100021. Epub 2019 May 17.
10
Cancer statistics for African Americans, 2019.2019 年非裔美国人癌症统计数据。
CA Cancer J Clin. 2019 May;69(3):211-233. doi: 10.3322/caac.21555. Epub 2019 Feb 14.
Zotero 插件